The Centers for Disease Control and Prevention and the U.S. Food and Drug Administration, in collaboration with state and local health departments, are continuing an investigation into cases of fungal endophthalmitis following use of two different products from Franck's Compounding Pharmacy in Ocala, Fla. The scope and root cause of this outbreak are still under active investigation. Health care personnel therefore are advised to stop use of all sterile triamcinolone-containing products purchased from Franck's until further information regarding the safety of these products is available. Unused sterile triamcinolone-containing products should be retained and notifications sent to state health departments for further testing by the FDA and CDC. The CDC will report further on the ongoing outbreak in this week